TouchENDOCRINOLOGY joins Prof Luca Valenti (University of Milan, Italy) at the Digital NAFLD Summit 2021 to discuss his hopes for the conference and the most exciting new developments in the field of non-alcoholic fatty liver disease (NAFLD).
Questions
- Could you give us an overview of the clinical spectrum of non-alcoholic fatty liver disease (NAFLD) and its prevalence? (00:18)
- What are the limitations of current treatment approaches for NAFLD? (00:56)Â
- What are the current most promising therapies under clinical investigation? (1:47)
- Why should healthcare professionals attend the NAFLD Summit this year? (02:46)
- What are you most looking forward to at the conference? (03:32)
Disclosures: Prof Valenti has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson
Filmed in coverage of the Digital NAFLD Summit 2021.
